A case of synchronous endometrial and occult ovarian cancers diagnosed after laparoscopic surgery

We report a case of occult ovarian cancer diagnosed by histopathological examination after a laparoscopic surgery that was performed for endometrial cancer. A 57-year-old postmenopausal woman (gravida 0), who had a history of undergoing myomectomy 22 years ago, was referred to our hospital for positive Pap cytology of the endometrium. Uterine curettage biopsy examination revealed endometrioid carcinoma of grade 1. Magnetic resonance imaging showed thickening of the endometrium and an endometriotic cyst in the left ovary. The patient underwent total laparoscopic hysterectomy, bilateral salpingo-oophorectomy, and bilateral pelvic lymphadenectomy. The pathological examination revealed endometrioid carcinoma in the uterine corpus and left ovary. Subsequently, she underwent omentectomy and para-aortic lymphadenectomy for staging of the ovarian cancer. No residual malignant lesions were identified. After the surgery, six cycles of a regimen of paclitaxel and carboplatin was administered. Moreover, there was no evidence of recurrence 10 months after the surgery. It is important to be aware of the possibility of coexisting ovarian malignancy with endometrial cancer, especially in patients of young age or in those with coexisting endometriosis.

[1]  D. Aoki,et al.  Clinicopathologic Analysis With Immunohistochemistry for DNA Mismatch Repair Protein Expression in Synchronous Primary Endometrial and Ovarian Cancers , 2014, International Journal of Gynecologic Cancer.

[2]  D. Bae,et al.  Prognostic Factors in Women With Synchronous Endometrial and Ovarian Cancers , 2014, International Journal of Gynecologic Cancer.

[3]  R. Kimmig,et al.  Synchronous Ovarian and Endometrial Cancer—an International Multicenter Case-Control Study , 2014, International Journal of Gynecologic Cancer.

[4]  Hong-yan Jin,et al.  Clinicopathological characteristics of patients with synchronous primary endometrial and ovarian cancers: A review of 43 cases. , 2013, Oncology letters.

[5]  N. Matsumura,et al.  Synchronous primary corpus and ovarian cancer: High incidence of endometriosis and thrombosis. , 2012, Oncology letters.

[6]  A. Mariani,et al.  Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study. , 2012, Gynecologic oncology.

[7]  B. Karlan,et al.  Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening. , 2010, Gynecologic oncology.

[8]  E. Paci,et al.  Coexisting endometrial and ovarian carcinomas: a retrospective clinicopathological study. , 2008, Pathology, research and practice.

[9]  Y. Chiang,et al.  Synchronous primary cancers of the endometrium and ovary , 2007, International Journal of Gynecologic Cancer.

[10]  R. Broaddus,et al.  Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  C. Holschneider,et al.  Coexisting Ovarian Malignancy in Young Women With Endometrial Cancer , 2005, Obstetrics and gynecology.

[12]  K. Lu,et al.  Risk Factors for Young Premenopausal Women With Endometrial Cancer , 2005, Obstetrics and gynecology.

[13]  R. Broaddus,et al.  Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. , 2004, Gynecologic oncology.

[14]  N. Hacker,et al.  Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  R. Burger,et al.  Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. , 2001, Gynecologic oncology.

[16]  S. Asa Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament. , 1999 .

[17]  P. Clement,et al.  Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament: Atlas of Tumor Pathology , 1999 .

[18]  L. Aaltonen,et al.  Cancer risk in mutation carriers of DNA‐mismatch‐repair genes , 1999, International journal of cancer.

[19]  A D Carothers,et al.  Cancer risk associated with germline DNA mismatch repair gene mutations. , 1997, Human molecular genetics.